Concepedia

Author

Silvia Frascerra

University of Pisa

Also Known As

E. Endert, S Frascerra, S. FRASCERRA, S. Frascerra, SILVIA FRASCERRA, Silvia Frascerra

75

Publications

4.9K

Citations

31

H-Index

69

Concepts

All Affiliations

University of PisaIstituto di Fisiologia ClinicaNational Research CouncilUniversity of FlorenceUniversity of Modena and Reggio Emilia
SF

About

Silvia Frascerra is an author at University of Pisa specializing in medicine, metabolic syndrome, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

21

1.4K

2

Health Sciences

10

10

851

3

Engineering

1

1

30

4

Allergy

1

1

14

5

Applied Physiology

1

1

90

Silvia Frascerra

×

48

Publications

4.8K

Citations

30

H-Index

YearCitations

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini, Elza Muscelli, Silvia Frascerra,

Journal of Clinical Investigation

2014

1.1K

Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes

Ele Ferrannini, Simona Baldi, Silvia Frascerra,

Diabetes

2016

691

Effect of insulin on uric acid excretion in humans

A. Quinones Galvan, Andrea Natali, Simona Baldi,

American Journal of Physiology-Endocrinology and Metabolism

1995

451

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

Stefania Camastra, Amalia Gastaldelli, Andrea Mari,

Diabetologia

2011

198

Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM

Riccardo C. Bonadonna, Enzo Bonora, Stefano Del Prato,

Diabetes

1996

186

Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes

Ele Ferrannini, Simona Baldi, Silvia Frascerra,

Diabetes Care

2017

165

Effect of Physiological Hyperinsulinemia on Gluconeogenesis in Nondiabetic Subjects and in Type 2 Diabetic Patients

Amalia Gastaldelli, Elena Toschi, Maura Pettiti,

Diabetes

2001

151

CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study

Alessandro Antonelli, Clodoveo Ferri, Poupak Fallahi,

Lara D. Veeken

2007

112

Muscle Metabolism and Exercise Tolerance in Subclinical Hypothyroidism: A Controlled Trial of Levothyroxine

Nadia Caraccio, Andrea Natali, Annamaria Sironi,

The Journal of Clinical Endocrinology & Metabolism

2005

110

Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists

Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi,

The Journal of Clinical Endocrinology & Metabolism

2009

100

Page 1